UniPharma Co., Ltd. (TPEX:6621)
Taiwan
· Delayed Price · Currency is TWD 12.85
-0.20 (-1.53%)
Apr 29, 2026, 1:45 PM CST
UniPharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 29 | 58.68 | 68.64 | 63.76 | 75.96 | Upgrade
|
| Short-Term Investments | 106.36 | 98.5 | 98.5 | 98.5 | 99.5 | Upgrade
|
| Cash & Short-Term Investments | 135.36 | 157.18 | 167.14 | 162.26 | 175.46 | Upgrade
|
| Cash Growth | -13.88% | -5.96% | 3.01% | -7.52% | -6.72% | Upgrade
|
| Accounts Receivable | 14.87 | 16.72 | 21.07 | 34.1 | 22.68 | Upgrade
|
| Other Receivables | 0.14 | 0.13 | 0.18 | 0 | 0.3 | Upgrade
|
| Receivables | 15.01 | 16.86 | 21.25 | 34.11 | 22.98 | Upgrade
|
| Inventory | 31.3 | 22.27 | 28.94 | 31.05 | 35.94 | Upgrade
|
| Prepaid Expenses | - | - | 0.06 | 0.32 | - | Upgrade
|
| Other Current Assets | 2.81 | 3.71 | 8.83 | 10.56 | 27.01 | Upgrade
|
| Total Current Assets | 184.47 | 200.01 | 226.23 | 238.28 | 261.39 | Upgrade
|
| Property, Plant & Equipment | 18.56 | 23.79 | 11.57 | 8.73 | 13.46 | Upgrade
|
| Long-Term Investments | 61.33 | 94.3 | 101.26 | 73.58 | 59.09 | Upgrade
|
| Other Intangible Assets | 3.54 | 3.58 | 1.94 | 2.22 | 2.53 | Upgrade
|
| Other Long-Term Assets | 7.1 | 7.3 | 9.07 | 9.77 | 11.71 | Upgrade
|
| Total Assets | 274.99 | 328.98 | 350.07 | 332.57 | 348.18 | Upgrade
|
| Accounts Payable | 18.05 | 14.49 | 22.25 | 6.09 | 27.66 | Upgrade
|
| Accrued Expenses | 11.11 | 8.83 | - | 0.59 | - | Upgrade
|
| Current Portion of Leases | 3.7 | 3.71 | 0.27 | 3.26 | 3.46 | Upgrade
|
| Current Unearned Revenue | 2.51 | 2.57 | 2.72 | 3.12 | 2.41 | Upgrade
|
| Other Current Liabilities | 2.57 | 3.56 | 11.87 | 15.71 | 13.27 | Upgrade
|
| Total Current Liabilities | 37.94 | 33.15 | 37.12 | 28.78 | 46.8 | Upgrade
|
| Long-Term Leases | 7.27 | 11.07 | - | 0.27 | 3.53 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.29 | 0.29 | 0.29 | Upgrade
|
| Total Liabilities | 45.2 | 44.22 | 37.4 | 29.33 | 50.61 | Upgrade
|
| Common Stock | 355.01 | 355.01 | 355.01 | 355.01 | 355.01 | Upgrade
|
| Additional Paid-In Capital | 0.38 | 0.38 | 0.38 | 0.38 | 17.94 | Upgrade
|
| Retained Earnings | -128.56 | -88.93 | -60.92 | -40.34 | -51.39 | Upgrade
|
| Treasury Stock | - | - | - | - | -3.91 | Upgrade
|
| Comprehensive Income & Other | 2.96 | 18.29 | 18.2 | -11.8 | -20.08 | Upgrade
|
| Shareholders' Equity | 229.79 | 284.75 | 312.67 | 303.24 | 297.57 | Upgrade
|
| Total Liabilities & Equity | 274.99 | 328.98 | 350.07 | 332.57 | 348.18 | Upgrade
|
| Total Debt | 10.96 | 14.78 | 0.27 | 3.53 | 6.99 | Upgrade
|
| Net Cash (Debt) | 124.39 | 142.4 | 166.87 | 158.73 | 168.46 | Upgrade
|
| Net Cash Growth | -12.64% | -14.67% | 5.13% | -5.78% | -1.63% | Upgrade
|
| Net Cash Per Share | 3.50 | 4.01 | 4.70 | 4.47 | 4.79 | Upgrade
|
| Filing Date Shares Outstanding | 35.5 | 35.5 | 35.5 | 35.5 | 35.2 | Upgrade
|
| Total Common Shares Outstanding | 35.5 | 35.5 | 35.5 | 35.5 | 35.2 | Upgrade
|
| Working Capital | 146.54 | 166.86 | 189.11 | 209.51 | 214.59 | Upgrade
|
| Book Value Per Share | 6.47 | 8.02 | 8.81 | 8.54 | 8.45 | Upgrade
|
| Tangible Book Value | 226.25 | 281.17 | 310.73 | 301.03 | 295.04 | Upgrade
|
| Tangible Book Value Per Share | 6.37 | 7.92 | 8.75 | 8.48 | 8.38 | Upgrade
|
| Machinery | 29.85 | 28.62 | 28.14 | 20.03 | 19.88 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.